Filling the need for trusted information on national health issues…

Trending on kff Open Enrollment Medicare Part D Medicaid Expansion

Kaiser Daily Global Health Policy ReportHIV/AIDS Search Results « » The Henry J. Kaiser Family Foundation

HIV/AIDS

  • your selections
Clear Search

Filter Results

date

Tags

  • results
GlaxoSmithKline’s ViiV Healthcare To Purchase Experimental HIV Medicines From Bristol-Myers Squibb For Up To $1.46B

Bloomberg Business: Glaxo to Pay Bristol-Myers Up to $1.46 Billion for HIV Drugs “GlaxoSmithKline Plc agreed to buy Bristol-Myers Squibb Co.’s portfolio of experimental HIV treatments for as much as $1.46 billion in two transactions, bolstering one of the U.K. drugmaker’s fastest-growing businesses…” (Serafino/Kitamura, 12/18). Financial Times: GSK spends up…

Global Fund Launches Investment Case For 2017-2019 Replenishment

ONE Blog: Global Fund kicks off fundraising effort to save 8 million lives Cornelia Lluberes, research assistant for global health policy at the ONE Campaign, discusses the Global Fund’s pre-replenishment meeting that took place this week in Japan, where the Investment Case for the Global Fund’s 2017-2019 Replenishment was presented.…

Blog Post Examines Global Health-Related Portions Of FY16 Omnibus Spending Bill

Center for Global Health Policy’s “Science Speaks”: Global HIV, tuberculosis programs flat funded in FY 2016 spending bill, yet again Rabita Aziz, policy research coordinator for the Center for Global Health Policy, discusses the global health-related aspects of the FY 2016 omnibus spending bill, which Congress released this week (12/16).

Aidspan Publishes New Issue Of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 277 of the “Global Fund Observer.” The newsletter features articles on various topics, including analyses of the fund’s $13 billion replenishment goal, investments in human rights programming, and efforts to…

Companies Must Not Place Pharmaceutical Profits Ahead Of People’s Health

Forbes: Why Martin Shkreli’s Price Hike May Hurt Everyone … Including You And The Pharmaceutical Industry Bruce Y. Lee, associate professor of international health at the Johns Hopkins Bloomberg School of Public Health, director of the Global Obesity Prevention Center, and director of operations research at the International Vaccine Access…

Ending HIV, TB, Malaria Requires Stronger Health Systems, Universal Access To Care

Huffington Post: We Are in This Boat Together Mustapha Kaloko, Africa Union commissioner for social affairs “…This week, I will join fellow global health leaders and representatives of the Global Fund partnership in Tokyo to address the challenge of funding stronger health systems to end HIV, TB, and malaria as…

Global Private Funding For HIV Totals $618M In 2014, FCAA Report Says

Philanthropy News Digest: Grantmaking for HIV/AIDS Totaled $618 Million in 2014, Report Finds “Philanthropic support for HIV/AIDS initiatives in low- and middle-income countries totaled $618 million in 2014, up eight percent from 2013, a report from Funders Concerned About AIDS [(FCAA)] finds. According to the report … the increase –…